Single agent oral topotecan (OT) as first-line treatment...

Lung Cancer 2000 / 9 Vol. 29; Iss. 1

Single agent oral topotecan (OT) as first-line treatment for patients (pts) with extensive disease (ED) small cell lung cancer (SCLC) ineligible for standard therapy: A phase II study

Eckardt, J.R, Palmer, M.C, Fanucchi, M.P, Gralla, R, Martins, H, Poulin, R, Fields, S.Z
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80025-2
Date:
September, 2000
File:
PDF, 113 KB
english, 2000
Conversion to is in progress
Conversion to is failed